Stock listing
BOATS:ZBIO Zenas BioPharma, Inc. Stock
US listing (BOATS) of Zenas BioPharma, Inc. · home listing NASDAQ:ZBIO
Follow Zenas BioPharma, Inc. into a list and get an email when it puts out news.
Home listing price · NASDAQ:ZBIO
$28.26 USD +2.33 (+9.0%)
Close on Nov 6, 2026 · This listing has no price on 6ix; the price shown is the home listing's, NASDAQ:ZBIO
- Day range
- $25.94 – $28.44 USDNov 6, 2026
- Volume
- 543,966 sharesNov 6, 2026
- Market cap
- $1.84B USDAt the close on Nov 6, 2026 · price × 65.18M shares outstanding
- 52-week range
- $13.50 – $44.60 USDLowest and highest trades, Nov 7, 2025 – Nov 6, 2026
- Traded on an average day
- $19.60M USDMedian day 546,483 shares · last 3 months, Aug 6, 2026 – Nov 6, 2026
Prices by listing
| Listing | Last | Change | Volume | Open | High | Low | Previous close | Price from |
|---|---|---|---|---|---|---|---|---|
| NASDAQ:ZBIO · Home | $28.26 USD | +2.33 (+9.0%) | 543,966 | $26.21 | $28.44 | $25.94 | $25.93 | Close on Nov 6, 2026 |
Daily closes
Last 3 months, Aug 6, 2026 – Nov 6, 2026 · NASDAQ:ZBIO · USD, adjusted for splits
| Day | Close | Change | % | Open | High | Low | Volume |
|---|---|---|---|---|---|---|---|
| $28.26 | +2.33 | +9.0% | $26.21 | $28.44 | $25.94 | 543,966 | |
| $25.93 | -2.53 | -8.9% | $28.10 | $28.49 | $25.79 | 822,021 | |
| $28.46 | +0.08 | +0.3% | $29.27 | $29.80 | $28.01 | 800,738 | |
| $28.38 | +0.76 | +2.8% | $27.85 | $29.05 | $27.84 | 572,811 | |
| $27.62 | -0.77 | -2.7% | $28.47 | $28.81 | $27.15 | 408,282 | |
| $28.39 | -0.37 | -1.3% | $28.35 | $29.11 | $27.91 | 358,069 | |
| $28.76 | -0.01 | 0.0% | $29.08 | $29.60 | $28.37 | 373,024 | |
| $28.77 | +1.47 | +5.4% | $27.10 | $29.07 | $27.03 | 391,455 | |
| $27.30 | +0.06 | +0.2% | $27.09 | $28.23 | $26.72 | 581,011 | |
| $27.24 | +0.37 | +1.4% | $27.18 | $28.17 | $26.68 | 371,646 | |
| $26.87 | -1.36 | -4.8% | $28.00 | $28.33 | $26.73 | 377,500 | |
| $28.23 | +0.15 | +0.5% | $27.95 | $28.83 | $27.51 | 406,000 | |
| $28.08 | -0.10 | -0.4% | $28.47 | $29.44 | $27.90 | 484,000 | |
| $28.18 | +1.47 | +5.5% | $26.38 | $29.71 | $26.38 | 549,000 | |
| $26.71 | +1.87 | +7.5% | $25.08 | $27.55 | $25.08 | 696,500 | |
| $24.84 | -0.56 | -2.2% | $25.36 | $25.96 | $24.51 | 661,700 | |
| $25.40 | +0.54 | +2.2% | $24.96 | $25.94 | $24.25 | 471,900 | |
| $24.86 | -0.30 | -1.2% | $24.82 | $26.49 | $24.39 | 425,100 | |
| $25.16 | -1.24 | -4.7% | $26.11 | $27.00 | $25.04 | 519,700 | |
| $26.40 | -0.86 | -3.2% | $26.93 | $27.49 | $26.30 | 602,500 | |
| $27.26 | +1.02 | +3.9% | $26.18 | $27.64 | $26.18 | 429,600 | |
| $26.24 | -1.94 | -6.9% | $27.98 | $27.98 | $25.51 | 557,500 | |
| $28.18 | +1.24 | +4.6% | $26.89 | $28.86 | $26.78 | 509,100 | |
| $26.94 | -0.89 | -3.2% | $27.87 | $28.14 | $26.28 | 357,600 | |
| $27.83 | -0.465 | -1.6% | $28.47 | $29.06 | $27.77 | 1,131,900 | |
| $28.30 | +0.355 | +1.3% | $28.47 | $29.20 | $27.84 | 1,513,600 | |
| $27.94 | +0.97 | +3.6% | $26.89 | $29.23 | $26.55 | 881,900 | |
| $26.97 | +0.21 | +0.8% | $26.99 | $28.38 | $26.54 | 623,200 | |
| $26.76 | -0.79 | -2.9% | $27.30 | $27.62 | $26.18 | 440,600 | |
| $27.55 | +0.60 | +2.2% | $27.07 | $28.23 | $26.46 | 615,300 | |
| $26.95 | -0.55 | -2.0% | $27.44 | $28.50 | $25.90 | 747,800 | |
| $27.50 | -2.13 | -7.2% | $29.51 | $30.12 | $25.70 | 962,900 | |
| $29.63 | -3.42 | -10.3% | $33.09 | $33.09 | $29.53 | 525,100 | |
| $33.05 | +0.50 | +1.5% | $32.55 | $33.84 | $32.15 | 452,800 | |
| $32.55 | +1.05 | +3.3% | $31.62 | $33.19 | $31.00 | 414,500 | |
| $31.50 | -0.47 | -1.5% | $32.04 | $32.04 | $31.25 | 2,515,200 | |
| $31.97 | -0.35 | -1.1% | $32.78 | $33.48 | $31.55 | 527,800 | |
| $32.32 | +0.39 | +1.2% | $31.89 | $33.23 | $31.59 | 746,400 | |
| $31.93 | +0.02 | +0.1% | $32.06 | $32.06 | $30.27 | 716,000 | |
| $31.91 | +0.79 | +2.5% | $31.00 | $32.00 | $30.66 | 634,600 | |
| $31.12 | +0.02 | +0.1% | $31.48 | $32.32 | $31.12 | 421,700 | |
| $31.10 | -1.19 | -3.7% | $31.88 | $31.89 | $30.73 | 646,900 | |
| $32.29 | -0.76 | -2.3% | $33.02 | $33.53 | $32.09 | 385,400 | |
| $33.05 | +0.17 | +0.5% | $32.65 | $33.84 | $32.31 | 441,200 | |
| $32.88 | -0.04 | -0.1% | $32.66 | $33.29 | $32.38 | 452,700 | |
| $32.92 | -0.21 | -0.6% | $33.42 | $33.66 | $32.37 | 515,100 | |
| $33.13 | +1.15 | +3.6% | $32.21 | $33.40 | $31.93 | 757,500 | |
| $31.98 | -0.34 | -1.1% | $32.20 | $32.73 | $31.55 | 432,300 | |
| $32.32 | +1.05 | +3.4% | $31.51 | $32.77 | $29.88 | 527,700 | |
| $31.27 | -1.35 | -4.1% | $32.27 | $32.38 | $31.19 | 439,100 | |
| $32.62 | -0.42 | -1.3% | $32.81 | $33.69 | $32.38 | 659,000 | |
| $33.04 | -0.73 | -2.2% | $33.80 | $33.99 | $31.91 | 651,600 | |
| $33.77 | +2.12 | +6.7% | $32.00 | $33.78 | $31.65 | 633,583 | |
| $31.65 | -0.64 | -2.0% | $32.40 | $32.48 | $30.95 | 481,882 | |
| $32.29 | +0.67 | +2.1% | $31.83 | $32.79 | $31.45 | 808,700 | |
| $31.62 | +0.37 | +1.2% | $30.72 | $32.20 | $29.50 | 1,172,500 | |
| $31.25 | -0.66 | -2.1% | $32.80 | $32.89 | $30.92 | 2,702,700 | |
| $31.91 | +1.41 | +4.6% | $30.22 | $31.96 | $30.22 | 659,800 | |
| $30.50 | +0.99 | +3.4% | $29.95 | $30.81 | $28.72 | 490,100 | |
| $29.51 | +0.31 | +1.1% | $28.76 | $30.31 | $28.16 | 630,000 | |
| $29.20 | -2.09 | -6.7% | $30.39 | $31.00 | $27.81 | 881,500 | |
| $31.29 | -1.15 | -3.5% | $32.05 | $32.97 | $31.12 | 461,600 | |
| $32.44 | +0.45 | +1.4% | $31.43 | $32.88 | $30.71 | 1,071,547 | |
| $31.99 | -0.44 | -1.4% | $32.24 | $32.70 | $31.61 | 409,916 | |
| $32.43 | +0.26 | +0.8% | $32.85 | $33.08 | $31.65 | 264,000 | |
| $32.17 | +0.31 | +1.0% | $31.51 | $33.00 | $31.32 | 676,900 |
- Ticker
- BOATS:ZBIO
- Asset type
- Stock
- Sector
- Health care
- Industry
- Biotechnology
- Exchange
- BOATS
- Currency
- USD
What changed lately
Latest news release · Oct 16, 2026
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Latest deck · 2026
Technical Presentation (2026)
Technical · 24 slides
Latest news
Zenas BioPharma Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Oct 16, 2026
Closed $26.71 (+7.5%) on Oct 19, 2026
Zenas BioPharma to Host Virtual R&D Event
Oct 6, 2026
Closed $26.94 (-3.2%) on Oct 6, 2026
Zenas BioPharma Announces Upcoming Presentations of Obexelimab Data in IgG4-Related Disease at the IgG4ward! 6th International Symposium on IgG4-Related Disease and ACR Convergence 2026
Sep 22, 2026
Closed $33.05 (+1.5%) on Sep 22, 2026
Zenas BioPharma to Host Obexelimab IgG4-RD Investor Event
Sep 8, 2026
Closed $33.05 (+0.5%) on Sep 8, 2026
Zenas BioPharma Reports Second Quarter 2026 Financial Results and Provides Corporate Update
Aug 13, 2026
Closed $29.20 (-6.7%) on Aug 13, 2026
Zenas BioPharma Announces Data from the Registrational Phase 3 INDIGO Trial of Obexelimab in Immunoglobulin G4-Related Disease (IgG4-RD), Simultaneously Presented at the EULAR 2026 Congress and Published in the New England Journal of Medicine
Jun 2, 2026
Closed $17.40 (+1.6%) on Jun 3, 2026
Zenas BioPharma Announces Submission of Biologics License Application to U.S. FDA for Obexelimab in IgG4-RD
May 29, 2026
Closed $18.40 (-0.9%) on May 29, 2026
Zenas BioPharma Announces Submission of Biologics License Application (BLA) to U.S. FDA for Obexelimab in IgG4-RD
May 28, 2026
Closed $18.56 (+2.6%) on May 28, 2026
Financings
Private placement of common stock
Oct 8, 2025
Announced: about US$120M · US$19 a share · Jefferies +1
Dealers: Jefferies (co-lead), Evercore ISI (co-lead)
Insiders: Certain directors and officers of the Company participate at a price of $20.85 per share
Royalty funding (5.5% royalty on worldwide net sales of obexelimab)
Sep 2, 2025
Announced: up to US$300M · Evercore
Dealers: Evercore
Buyers: Royalty Pharma plc (up to $300 million in funding in exchange for a 5.5% royalty on worldwide net sales of obexelimab)
Use of proceeds: Obexelimab development and a potential IgG4-RD commercial launch in the first half of 2027, subject to FDA approval
Decks
Technical Presentation (2026)
Technical · 24 slides · 2026
Merger or Acquisition (October 2025)
Merger or acquisition · 49 slides · Oct 8, 2025
Investor Presentation (June 2025)
Investor deck · 25 slides · Jun 4, 2025
Investor Presentation (December 2024)
Investor deck · 36 slides · Dec 2, 2024
Zenas BioPharma, Inc. on 6ix
- Sector
- Health care
- Industry
- Biotechnology
- News releases
- 23 in the last 12 months · 32 in all · newest Oct 16, 2026 · oldest 2025
- Decks
- 4 decks · latest 2026
Where Zenas BioPharma, Inc. is listed
| Listing | Exchange | Country | Currency |
|---|---|---|---|
| NASDAQ:ZBIO · Home listing | NASDAQ | United States | USD |
| BOATS:ZBIO · This page | BOATS | United States | USD |
Log in to ask 6ix AI your own questions about Zenas BioPharma, Inc.